Objective: To compare overall survival (OS) of maintenance chemotherapy (P and PP) to surveillance (S) in women with advanced ovarian/fallopian tube/peritoneal (O/PC/FT) cancer who attained complete clinical response (CCR) following first-line platinum-taxane therapy.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Gynecologic Oncology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect